Morgan Keegan Maintains Outperform on HCP

Morgan Keegan is out with its report today on HCP HCP, maintaining Outperform. In its report, Morgan Keegan writes, "HCP is the best-diversified healthcare REIT. Management has identified growth opportunities across asset classes through direct ownership, debt investments, and institutional joint ventures, with a focus on high-quality assets. As a result, despite being the largest healthcare REIT, we expect it to be one of the faster-growing. We project 4%-6% long-term FFO and FAD growth." Morgan Keegan maintains a $4 PT on HCP. Shares of HCP closed Tuesday at $34.47, down 0.49% from Monday's close.